Skip to main content

Published locations for FDA extends review of pegylated interferon for MS, Biogen says

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA extends review of pegylated interferon for MS, Biogen says

User login

  • Reset your password
  • /content/fda-extends-review-pegylated-interferon-ms-biogen-says
  • /internalmedicinenews/article/81043/multiple-sclerosis/fda-extends-review-pegylated-interferon-ms
  • /internalmedicine/article/81043/multiple-sclerosis/fda-extends-review-pegylated-interferon-ms-biogen
  • /neurology/article/81043/multiple-sclerosis/fda-extends-review-pegylated-interferon-ms-biogen-says
  • /clinicalneurologynews/article/81043/multiple-sclerosis/fda-extends-review-pegylated-interferon-ms